On the threshold of obtaining results from a clinical trial of a newly developed vaccine against hepatitis C virus (HCV) in a population at risk for infection, investigators have described the challenges they have encountered and the prospects for success ." A potential new vaccine to prevent HCV infection has been tested in Baltimore and at two other sites in the US, and the results of that trial will be available by summer," said MD, PhD, Professor of Medicine and Oncology, Johns Hopkins University School of Medicine. He said, "we are hopeful that this vaccine will be able to protect against HCV and stem the rising tide of HCV infections in the US," The need for an effective vaccine to prevent new HCV infections is evident from the continued increase in infections in both the US and globally, despite the availability of curative treatment with direct-acting antivirals (DAAs)."An…